Skip to main content

Table 2 Expression levels of the assessed genes in the patients' groups

From: Evaluation of the HOXA9 and MEIS1 genes as a potential biomarker in adult acute myeloid leukemia

Ā 

AML

Control group

P value

HOXA9

14.6 (0.22ā€“921.1)

1 (0.06ā€“6.1)

ā€‰<ā€‰0.001

MEIS1

33.9 (0ā€“1716)

1 (0.51ā€“1.29)

ā€‰<ā€‰0.001

  1. Data are presented as median (minā€“max)